Recent 8-K filings for GANX

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:05 UTC earnings item 2.02item 9.01

  Gain Therapeutics Q1 net loss $0.13/sh; Phase 1b biomarker data support GT-02287

source · GANX on sec.gov